SEARCH RESULT

Total Matching Records found : 1293

Promote Indian drugs, US health groups urge Obama -Sushmi Dey

-The Times of India NEW DELHI: Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing "high-quality, low-cost generic medicines essential for health care around the world". This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after...

More »

Private sector, ‘care economy’ will be key engines of job creation for next 5 years –UN report

-The United Nations Private sector services, such as business and administrative services, and real estate, as well as related industries, will employ more than a third of the global workforce over the next five years, according to new data released by the United Nations labour agency. "Service sector employment will remain the most dynamic with respect to job creation in the next five years," said Raymond Torres, a head researcher of...

More »

Union Budget likely to provide big thrust to ‘Make In India’ -Sidhartha & Surojit Gupta

-The Times of India NEW DELHI: The BJP government's 'Make in India' initiative could get top billing in the 2015-16 Union Budget with tax breaks and other measures for several sectors. Make in India is the centerpiece of the Narendra Modi administration's bid to revive Manufacturing activities and create millions of jobs. With the Chinese economy slowing, India senses an opportunity in the industrial sector. A blueprint for the 25 identified sectors was...

More »

Fillip to cheaper hepatitis C drug -GS Mudur

-The Telegraph New Delhi: India's patent regulating agency today rejected a US company's patent claim on a drug to treat hepatitis C, raising hopes that generic drug makers could now produce cheaper versions of the medicine. The Indian Patents Controller has denied a patent to sofosbuvir from Gilead, a US biopharmaceutical company that had last year pledged to make the oral drug available in India and 90 other developing countries at $900...

More »

Arvind Panagariya’s plan for NITI Aayog: Focus on labour reforms, SMEs -P Vaidyanathan Iyer

-The Indian Express For Arvind Panagariya, the first Vice-Chairman of NITI Aayog, policy-making, rather than planning, will be his top priority. In his first interaction with officers of the erstwhile Planning Commission, he spoke at length on the need to push through labour reforms and strengthen the SME (small and medium enterprise) segment - the backbone of Manufacturing - to take India up several notches in the competition ladder. On Tuesday, his...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close